Brief: Genfit Announces Launch By Labcorp Of NASHnext
May 3 (Reuters) - GENFIT GNFT.PA :
* ANNOUNCES THE LAUNCH BY LABCORP OF NASHNEXT, A NOVEL
NONINVASIVE
DIAGNOSTIC TEST POWERED BY GENFIT'S NIS4 TECHNOLOGY TO IDENTIFY
PATIENTS WITH AT-RISK NASH
* TEST IS OFFERED EXCLUSIVELY IN THE U.S. AND CANADA THROUGH
LABCORP
Source text for Eikon: ID:nGNE78ZPn8
Further company coverage: GNFT.PA , LH.N
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Genfit SA
See all newsFrance's Genfit H1 revenue falls due to absence of milestone payments
French and Benelux stocks-Factors to watch on September 15
Brief: Genfit SA - Advances Nangibotide In Phase 2 Clinical Investigation In Aclf
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Genfit March 31 Cash And Cash Equivalents EUR 136.1 Million